Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2021-04-16 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
2020年度独立董事述职报告（袁洪）
Board/Management Information Classification · 95% confidence The document is a detailed report by an independent director of the company for the year 2020, describing the director's duties, attendance at board meetings, opinions on various board resolutions, committee work, and efforts to protect investor rights. It is a formal report on the director's activities and responsibilities during the year, not an announcement or a brief summary. The content focuses on board and management oversight and governance activities rather than financial results or audit opinions. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management activities. The document length is 4268 characters, which is sufficient for a substantive report rather than a brief announcement. There is no indication that this is an audit report, earnings release, or regulatory filing. Hence, the classification is MANG with high confidence.
2021-04-16 Chinese
2020年度非经营性资金占用及其他关联资金往来的专项说明
Audit Report / Information Classification · 95% confidence The document is titled as a "专项说明" (special explanation) regarding non-operating fund occupation and other related party fund transactions for the year 2020 of 三诺生物传感股份有限公司. It includes a summary table of related party fund transactions and is issued by a certified public accounting firm (信永中和会计师事务所). The document references the audited financial statements for 2020 and states that the summary table should be read together with the audited financial statements. The document is a detailed explanatory note on a specific financial topic related to the company's 2020 financials, prepared to comply with regulatory requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange. It is not a full annual report (10-K), nor a general audit report (AR) since it focuses on a specific issue. It is not a short announcement or certification but a detailed special explanation. This type of document fits best under Audit Report / Information (AR) as it is a standalone audit-related report on a specific financial matter, separate from the full annual report. The document length is 2503 characters, which is relatively short but contains substantive financial data and audit-related content, so it is not a mere announcement (RPA) or regulatory filing (RNS). Therefore, the classification is AR with high confidence.
2021-04-16 Chinese
中信证券股份有限公司关于三诺生物使用闲置募集资金和自有资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the use of idle raised funds and own funds by SanNuo Bio-sensing Co., Ltd. for cash management. It references regulatory approvals, fundraising details, investment purposes, risk analysis, and internal approvals. The document is not a full financial report but rather a formal opinion or verification related to the use of funds, consistent with an audit or review report. It does not contain comprehensive financial statements or quarterly/yearly financial results. The length is under 5,000 characters, but the content is substantive and detailed, not a mere announcement. The document fits best as an Audit Report / Information (AR) because it involves verification and compliance opinions related to fundraising and fund usage, consistent with audit or regulatory review reports.
2021-04-16 Chinese
关于计提信用减值损失及资产减值损失的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by SanNuo Biological Sensor Co., Ltd. regarding the provision for credit impairment losses and asset impairment losses for the fiscal year ending December 31, 2020. It details the reasons, scope, and amounts of impairment losses, including credit losses on receivables and asset impairments such as inventory and goodwill. The document references compliance with accounting standards and mentions that the impairment provisions have been audited by an accounting firm. It also states that the detailed content is available in the company's 2020 Annual Report. The document length is 3720 characters, which is relatively short and primarily serves as an announcement of impairment provisions rather than a full financial report. It does not contain comprehensive financial statements or detailed financial analysis itself. Therefore, according to the "Menu vs Meal" rule, this document is an announcement related to financial reporting but is not the full Annual Report (10-K). It is also not a certification letter or a regulatory compliance filing. The best fitting category is Regulatory Filings (RNS) as a general announcement of impairment provisions and related financial impacts that do not constitute a full report.
2021-04-16 Chinese
关于变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policy by the company 三诺生物传感股份有限公司. It details the reasons for the change, the new accounting standards adopted, the impact on financial statements, and includes opinions from the board, independent directors, and the supervisory board. The document does not contain actual financial statements or detailed financial data but rather explains the policy change and its rationale. It is a regulatory announcement about accounting policy changes, not a full financial report or audit report. Therefore, it fits best under Regulatory Filings (RNS). The document length is 2554 characters, which is relatively short and consistent with an announcement rather than a full report.
2021-04-16 Chinese
《公司章程》修订对照说明
Governance Information Classification · 95% confidence The document is a detailed announcement regarding amendments to the company's Articles of Association (公司章程) including specific changes to business scope and shareholder meeting powers. It includes the text of original and revised articles and states that these amendments require shareholder approval at a general meeting. There is no financial data, no audit or financial report, no earnings data, no management discussion of financial results, no legal proceeding updates, no capital raising or share transactions. The document is a formal announcement of changes to governance documents, specifically the company's bylaws or articles of association. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is about 3,000 characters, which is substantive and not a mere announcement of a report publication. Therefore, the classification is CGR with high confidence.
2021-04-16 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.